• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

NEDD9 provides mechanistic insight into the coagulopathy of COVID-19.

作者信息

Rizzo Alicia N, Yuan Jason X-J

机构信息

Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine University of Colorado Aurora Colorado USA.

Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine University of California, San Diego La Jolla California USA.

出版信息

Pulm Circ. 2022 May 11;12(2):e12087. doi: 10.1002/pul2.12087. eCollection 2022 Apr.

DOI:10.1002/pul2.12087
PMID:35599982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9111000/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ec/9248788/ba2a56d7c71b/PUL2-12-e12087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ec/9248788/ba2a56d7c71b/PUL2-12-e12087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ec/9248788/ba2a56d7c71b/PUL2-12-e12087-g001.jpg

相似文献

1
NEDD9 provides mechanistic insight into the coagulopathy of COVID-19.NEDD9为深入了解新冠病毒病的凝血病提供了机制方面的见解。
Pulm Circ. 2022 May 11;12(2):e12087. doi: 10.1002/pul2.12087. eCollection 2022 Apr.
2
Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes.凝血功能障碍是合并 2 型糖尿病的 COVID-19 住院患者发生肺部以外死亡的主要风险因素。
BMJ Open Diabetes Res Care. 2020 Nov;8(2). doi: 10.1136/bmjdrc-2020-001851.
3
A Prospective Study of Specialized Coagulation Parameters in Admitted COVID-19 Patients and Their Correlation With Acute Respiratory Distress Syndrome and Outcome.新冠肺炎住院患者特殊凝血参数的前瞻性研究及其与急性呼吸窘迫综合征和预后的相关性
Cureus. 2021 Aug 26;13(8):e17463. doi: 10.7759/cureus.17463. eCollection 2021 Aug.
4
Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19.了解典型急性呼吸窘迫综合征和严重 COVID-19 的病理生理学。
Expert Rev Respir Med. 2022 Apr;16(4):437-446. doi: 10.1080/17476348.2022.2057300. Epub 2022 Mar 30.
5
Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immune-related disease or common direct risk factors.特发性/免疫相关性疾病或共同直接危险因素所致急性呼吸窘迫综合征中凝血功能障碍和肺泡上皮损伤的生物标志物特征。
Crit Care. 2019 Aug 19;23(1):283. doi: 10.1186/s13054-019-2559-6.
6
Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.辛伐他汀可阻断 SARS-CoV-2 核衣壳蛋白对血管内皮细胞的直接激活。
J Virol. 2021 Nov 9;95(23):e0139621. doi: 10.1128/JVI.01396-21. Epub 2021 Sep 22.
7
Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy.新冠病毒感染所致凝血病的血液学表型：与典型脓毒症所致凝血病大不相同。
J Clin Med. 2020 Sep 5;9(9):2875. doi: 10.3390/jcm9092875.
8
Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.重组 ACE2 表达是 SARS-CoV-2 感染原代人血管内皮细胞并诱导炎症和促凝反应所必需的。
mBio. 2020 Dec 11;11(6):e03185-20. doi: 10.1128/mBio.03185-20.
9
Pulmonary coagulopathy as a new target in lung injury--a review of available pre-clinical models.肺凝血病作为肺损伤的新靶点——现有临床前模型综述
Curr Med Chem. 2008;15(6):588-95. doi: 10.2174/092986708783769696.
10
Adult respiratory distress syndrome: do selective anticoagulants help?成人呼吸窘迫综合征：选择性抗凝剂有帮助吗？
Am J Respir Med. 2002;1(6):383-91. doi: 10.1007/BF03257165.

引用本文的文献

1
Demultiplexing of single-cell RNA-sequencing data using interindividual variation in gene expression.利用基因表达中的个体间差异对单细胞RNA测序数据进行解复用。
Bioinform Adv. 2024 Jun 8;4(1):vbae085. doi: 10.1093/bioadv/vbae085. eCollection 2024.

本文引用的文献

1
Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS-CoV-2 infection.肺内皮NEDD9与SARS-CoV-2感染所致急性呼吸窘迫综合征的血栓前病理表型
Pulm Circ. 2022 May 11;12(2):e12071. doi: 10.1002/pul2.12071. eCollection 2022 Apr.
2
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.SARS-CoV-2 相关 COVID-19 呼吸衰竭患者应用阿替普酶的研究：一项先锋性、快速适应、实用、随机对照试验。
Chest. 2022 Mar;161(3):710-727. doi: 10.1016/j.chest.2021.09.024. Epub 2021 Sep 27.
3
Advancing precision medicine for acute respiratory distress syndrome.
推进急性呼吸窘迫综合征精准医学。
Lancet Respir Med. 2022 Jan;10(1):107-120. doi: 10.1016/S2213-2600(21)00157-0. Epub 2021 Jul 23.
4
COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year.COVID-19 相关凝血功能障碍与抗血栓药物——1 年后的经验教训。
Lancet Haematol. 2021 Jul;8(7):e524-e533. doi: 10.1016/S2352-3026(21)00105-8. Epub 2021 Apr 27.
5
NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation.NEDD9 是肺循环中血小板-内皮黏附的新型可修饰介体。
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1533-1545. doi: 10.1164/rccm.202003-0719OC.
6
Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19.新型冠状病毒肺炎患者的肺血管内皮功能障碍与血栓并发症。
Am J Respir Cell Mol Biol. 2021 Apr;64(4):407-415. doi: 10.1165/rcmb.2020-0359PS.
7
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.COVID-19 和凝血：SARS-CoV-2 感染的出血和血栓形成表现。
Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.
8
Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.循环 NEDD9 在肺动脉高压中增加：一项多中心回顾性分析。
J Heart Lung Transplant. 2020 Apr;39(4):289-299. doi: 10.1016/j.healun.2019.12.002. Epub 2019 Dec 31.
9
NEDD9 targets to promote endothelial fibrosis and pulmonary arterial hypertension.NEDD9 将 靶向 以促进内皮纤维化和肺动脉高压。
Sci Transl Med. 2018 Jun 13;10(445). doi: 10.1126/scitranslmed.aap7294.
10
Clinical trials in acute respiratory distress syndrome: challenges and opportunities.急性呼吸窘迫综合征的临床试验：挑战与机遇。
Lancet Respir Med. 2017 Jun;5(6):524-534. doi: 10.1016/S2213-2600(17)30188-1. Epub 2017 May 26.